Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine

Clinical trial NCT05019248 · UNKNOWN

Trial details

NCT number: NCT05019248
Sponsor: Heinrich-Heine University, Duesseldorf
Status: UNKNOWN
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing-Remitting Vaccine Response Impaired

Start date: 2020-09-01
Primary completion: 2021-12-31
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.